SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $27.58 million. The enterprise value is $26.62 million.
Market Cap | 27.58M |
Enterprise Value | 26.62M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ICU has 3.11 million shares outstanding. The number of shares has increased by 415.18% in one year.
Shares Outstanding | 3.11M |
Shares Change (YoY) | +415.18% |
Shares Change (QoQ) | +209.67% |
Owned by Insiders (%) | 11.82% |
Owned by Institutions (%) | 5.06% |
Float | 2.95M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 66.61 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68
Current Ratio | 0.68 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -41.56 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -850.50% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.81M |
Employee Count | 12 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.77% in the last 52 weeks. The beta is -1.01, so ICU's price volatility has been lower than the market average.
Beta (5Y) | -1.01 |
52-Week Price Change | -31.77% |
50-Day Moving Average | 8.80 |
200-Day Moving Average | 14.38 |
Relative Strength Index (RSI) | 56.40 |
Average Volume (20 Days) | 1,103,524 |
Short Selling Information
The latest short interest is 117,117, so 3.77% of the outstanding shares have been sold short.
Short Interest | 117,117 |
Short Previous Month | 952,359 |
Short % of Shares Out | 3.77% |
Short % of Float | 3.97% |
Short Ratio (days to cover) | 0.91 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -13.58M |
Pretax Income | -33.67M |
Net Income | -33.67M |
EBITDA | -32.88M |
EBIT | -32.88M |
Earnings Per Share (EPS) | -$25.00 |
Balance Sheet
The company has $5.02 million in cash and $4.06 million in debt, giving a net cash position of $962,000 or $0.31 per share.
Cash & Cash Equivalents | 5.02M |
Total Debt | 4.06M |
Net Cash | 962,000 |
Net Cash Per Share | $0.31 |
Equity (Book Value) | -4.47M |
Book Value Per Share | -1.44 |
Working Capital | -3.11M |
Cash Flow
Operating Cash Flow | -11.48M |
Capital Expenditures | n/a |
Free Cash Flow | -11.48M |
FCF Per Share | -$4.28 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -415.18% |
Shareholder Yield | -415.18% |
Earnings Yield | -122.06% |
FCF Yield | -41.62% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 10, 2024. It was a reverse split with a ratio of 1:25.
Last Split Date | Jun 10, 2024 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |